Form 4 for ADPT Adaptive Biotechnologies Corp
Accepted 2021-09-09 00:00:00 ET · period of report 2021-09-07 · accession 0001209191-21-055367 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-09-09 | 2021-09-07 | ADPT | Taylor Stacy L | SVP, GC | M - OptEx | $6.55 | +495 | 15.5K | +3% | +$3,242 |
| D | 2021-09-09 | 2021-09-07 | ADPT | Taylor Stacy L | SVP, GC | S - Sale+OE | $40.00 | -495 | 15.0K | -3% | -$19.8K |
| D | 2021-09-09 | 2021-09-07 | ADPT | Taylor Stacy L | SVP, GC | M - OptEx | $0.00 | -495 | 15.4K | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-07 | M | A | 495 | $6.55 | 15,531 | D | — | — | |
| 2 | Common | Common Stock | 2021-09-07 | S | D | 495 | $40.00 | 15,036 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2021-09-07 | M | D | 495 | $0.00 | 15,443 | D | $6.55 · — to 2028-04-24 | 495 Common Stock | (F2) The options vested with respect to 1/4 of such shares on March 12, 2019, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested. |